ftInvstr
ERIS · Healthcare ₹1319.0 +1.76% Mkt Cap ₹18296 Cr

ERIS

Healthcare Drug Manufacturers - Specialty & Generic
₹1319.0
+1.76% today · 30d -5.11%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for ERIS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹873 Cr
+12.97% YoY
NET PROFIT
₹143 Cr
+14.56% YoY
OPM
34.1%
-1.92pp YoY
EPS
₹10.28
PE 28.22
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-32.1%, h2=-27.2%, h3=-27.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
ERIS28.2214.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
60
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation REASONABLE 60
Growth STRONG 72
Profitability HIGH 75
Technicals NEUTRAL 55
Risk LOW 80
Key Stats
TTM PE
28.22
P/B
4.64
52W HIGH
₹1818.8
OFF HIGH
-27.48%
DIV YIELD
1.09%
MKT CAP
₹18296 Cr
◉ Active Signals
MACDNeutral0.6277
RSI(14)Neutral44.38
Near 52W LowBearish9.92
Street Consensus
10 analysts
₹1661.2
mean target
Low ₹1435.0Now ₹1319.0High ₹1780.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ERIS and at what entry.

Sign up freeSign in